{"id":885153,"date":"2025-09-10T09:41:23","date_gmt":"2025-09-10T13:41:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/"},"modified":"2025-09-10T09:41:23","modified_gmt":"2025-09-10T13:41:23","slug":"important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/","title":{"rendered":"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf"},"content":{"rendered":"
\n

PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) — <\/p>\n

\n
\n Applied Therapeutics <\/u>
\n <\/strong>
\n
\n (NASDAQ: APLT) \u2013 Class Action Reaches Settlement:<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased <\/strong>
\n Applied Therapeutics <\/strong>
\n (NASDAQ: APLT) shares prior to <\/strong>
\n January 3, 2024,<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/applied-therapeutics-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085 to learn more. <\/strong>\n <\/p>\n

\n WHY?<\/strong> As alleged in a recently filed securities fraud class action complaint, Applied Therapeutics, Inc. (NASDAQ: APLT), through certain of its officers, provided positive statements to investors while, at the same time, disseminating false and materially misleading statements and\/or concealing material adverse facts concerning the true state of Applied Therapeutics\u2019 Phase III INSPIRE trial; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study. The Complaint further alleges that such statements absent these material facts caused Plaintiff and other shareholders to purchase Applied Therapeutics\u2019 securities at artificially inflated prices.<\/p>\n

On August 25, 2025, the parties reported to the Court that they had agreed to settle the securities fraud class action.<\/strong><\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased <\/strong>
\n Applied Therapeutics <\/strong>
\n (NASDAQ: APLT) shares prior to <\/strong>
\n January 3, 2024,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/applied-therapeutics-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. <\/strong>$APLT #AppliedTherapeutics<\/p>\n

\n
\n Elevance Health Inc. <\/u>
\n <\/strong>
\n
\n (NYSE: ELV)<\/u>
\n <\/strong>
\n :<\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Elevance Health Inc. (NYSE: ELV). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased <\/strong>
\n Elevance Health Inc. <\/strong>
\n (NYSE: ELV) shares prior to <\/strong>
\n April 18, 2024,<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. <\/strong>
\n
\n Please <\/strong>
\n visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/elevance-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085, to learn more. <\/strong>\n <\/p>\n

\n WHY?<\/strong> As alleged in a recently filed federal securities fraud class action complaint, Elevance Health Inc. (NYSE: ELV), through certain of its officers, represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. In fact, sicker patients with higher acuity tended to remain on Medicaid after redetermination, leading to higher per-patient costs. This increase in cost was occurring at a rate that was not adequately reflected in Elevance\u2019s rate negotiations with the states or in its financial guidance for 2024. As a result, the Complaint alleges Defendants\u2019 positive statements concerning Elevance\u2019s close monitoring of the redeterminations, the actuarial soundness of its rates and the prudence of its forecasts were materially misleading and\/or lacked a reasonable basis.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased <\/strong>
\n Elevance Health Inc. <\/strong>
\n (NYSE: ELV) shares prior to <\/strong>
\n April 18, 2024,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/elevance-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. <\/strong>$ELV #Elevance<\/p>\n

\n
\n LifeMD, Inc. (NASDAQ: LFMD)<\/u>
\n <\/strong>
\n :<\/strong>\n <\/p>\n

The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased <\/strong>
\n LifeMD, Inc. (NASDAQ: LFMD), <\/strong>
\n shares prior to <\/strong>
\n May 7, 2025,<\/strong>
\n and still hold shares today, y<\/strong>
\n ou can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Nutex shares between <\/strong>
\n May 7, 2025 and August 5, 2025<\/strong>
\n ,<\/strong>
\n you can participate in the class action. You are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/lifemd-shareholder-investigation\/<\/strong>
\n <\/a>
\n contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. <\/strong>\n <\/p>\n

\n WHY:<\/strong> As alleged in a recently filed federal securities fraud class action complaint, LifeMD, Inc. (NASDAQ: LFMD), through certain of its officers, made false and\/or misleading statements and\/or failed to disclose that: (1) Defendants materially overstated LifeMD\u2019s competitive position; (2) Defendants were reckless in raising LifeMD\u2019s 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD\u2019s RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, Defendants\u2019 statements about LifeMD\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased <\/strong>
\n LifeMD, Inc. <\/strong>
\n (NASDAQ: LFMD) shares prior to <\/strong>
\n May 7, 2025,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/lifemd-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased LifeMD shares between <\/strong>
\n May 7, 2025 and August 5, 2025<\/strong>
\n ,<\/strong>
\n you can participate in the class action.<\/strong> $LFMD #LifeMD<\/p>\n

\n
\n Quantum Corporation <\/u>
\n <\/strong>
\n
\n (NASDAQ: QMCO):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Quantum Corporation (NASDAQ: QMCO). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased <\/strong>
\n Quantum Corporation <\/strong>
\n (NASDAQ: QMCO) shares prior to <\/strong>
\n November 15, 2024,<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Pleasec visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/quantum-corp-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. <\/strong>
\n If, alternatively, you <\/strong>
\n purchased or otherwise<\/strong>
\n acquired Quantum Corporation securities between November 15, 2024, and<\/strong>
\n August 18, 2025, inclusive (the \u201cClass Period\u201d), you may participate in the class action.<\/strong>\n <\/p>\n

\n WHY? <\/strong>As alleged in a recently filed federal securities fraud class action complaint, Quantum Corporation (NASDAQ: QMCO), through certain of its officers, made false and\/or misleading statements and\/or failed to disclose that: (1) Quantum improperly recognized revenue during the fiscal year ended March 31, 2025; (2) as a result, Quantum would need to restate its previously filed financial statements for the fiscal third quarter ended December 31, 2024; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all times.<\/p>\n

WHAT YOU CAN DO NOW:<\/strong>If you purchased <\/strong>Quantum Corporation <\/strong>(NASDAQ: QMCO) shares prior to <\/strong>November 15, 2024,<\/strong> and still hold shares today, <\/strong>you are encouraged to visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/quantum-corp-shareholder-investigation\/<\/strong><\/a>, contact Joshua Grabar at <\/strong>jgrabar@grabarlaw.com<\/strong><\/a>, <\/strong>or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. <\/strong>If you <\/strong>purchased or otherwise<\/strong>acquired Quantum Corporation securities between November 15, 2024, and<\/strong>August 18, 2025, inclusive (the \u201cClass Period\u201d), you may participate in the class action. <\/strong>$QMCO #QuantumCorp<\/p>\n

\n Attorney Advertising Disclaimer<\/a>\n <\/p>\n

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: \u00a0267-507-6085
Email: jgrabar@grabarlaw.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics (NASDAQ: APLT) \u2013 Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/applied-therapeutics-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call 267-507-6085 to learn more. WHY? As alleged in a recently filed securities fraud class action complaint, … <\/p>\n

Continue reading “Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-885153","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImportant Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics (NASDAQ: APLT) \u2013 Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/applied-therapeutics-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call 267-507-6085 to learn more. WHY? As alleged in a recently filed securities fraud class action complaint, … Continue reading "Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T13:41:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf\",\"datePublished\":\"2025-09-10T13:41:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/\"},\"wordCount\":1276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/\",\"name\":\"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=\",\"datePublished\":\"2025-09-10T13:41:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/","og_locale":"en_US","og_type":"article","og_title":"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics (NASDAQ: APLT) \u2013 Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/applied-therapeutics-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call 267-507-6085 to learn more. WHY? As alleged in a recently filed securities fraud class action complaint, … Continue reading \"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-10T13:41:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf","datePublished":"2025-09-10T13:41:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/"},"wordCount":1276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/","name":"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=","datePublished":"2025-09-10T13:41:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjc0OSM3MTQwMzYzIzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-applied-therapeutics-inc-nasdaq-aplt-elevance-health-inc-nyse-elv-lifemd-inc-nasdaq-lfmd-and-quantum-corporation-nasdaq-qmco-grabar-l\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/885153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=885153"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/885153\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=885153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=885153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=885153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}